Pellucid Lifesciences Pvt. Ltd., headquartered in Ahmedabad, India, is a biotechnology-driven company specializing in the research, development, and manufacturing of high-quality probiotic strains for human health, animal nutrition, and aquaculture. Founded by industry experts with a vision to deliver sustainable and scientifically validated probiotic solutions, Pellucid has rapidly emerged as a globally recognized player in the field of microbiome health and functional fermentation.
Core Business
The core business of Pellucid Lifesciences revolves around probiotic biotechnology—offering functional microbial solutions that improve health, performance, and sustainability across multiple sectors. The company operates on a B2B model, supplying finished formulations and bulk probiotic strains to pharmaceutical, nutraceutical, feed, and aqua feed industries globally.
Pellucid’s fully integrated operations include strain isolation, fermentation, downstream processing, and formulation—all under strict quality control systems compliant with international regulations.
Product and Service Offerings
Pellucid offers an extensive portfolio of proprietary probiotic strains and customized formulations, including:
-
Probiotic Strains (Standalone and Blends):
- Bacillus coagulans BCP92
- Bacillus clausii PBC429
- Bacillus subtilis BSP110
- Bacillus licheniformis BLP92
-
Human Probiotics:
- Products for Inflammatory Bowel Disease (IBD)
- Support for Antibiotic-associated and Infectious Diarrhea
- Immune modulation supplements
-
Animal Probiotics:
- Gut health enhancers for poultry, swine, and ruminants
- Feed efficiency and pathogen resistance solutions
- Immune support and stress resilience formulations
-
Aqua Probiotics:
- Microbiota balancers for shrimp and fish gut
- Water purification microbes for ammonia and nitrite control
- Growth performance boosters
The company offers tailor-made probiotic blends based on customer specifications and regional gut health challenges.
Specialization and Unique Selling Proposition
Pellucid’s specialization lies in its strain-specific and application-focused R&D, backed by proprietary fermentation technology and clinical validation. Key differentiators include:
- Spore-Forming Strains: Ensures heat stability, long shelf life, and survivability through gastrointestinal transit.
- High CFU Concentration: Products standardized to 10⁹ CFU/g and higher for therapeutic efficacy.
- Custom Formulations: Sector-specific solutions developed through collaborative projects with clients and research institutes.
- Global Regulatory Dossiers: Dossiers ready for FSSAI, EFSA, FDA, and ASEAN country submissions.
Pellucid strains demonstrate scientifically backed bioactivity including pathogen inhibition, SCFA production, immune modulation, and nutrient assimilation enhancement.
Financial Performance
While privately held and not publicly disclosing detailed financials, Pellucid Lifesciences has shown strong growth in the competitive biotech sector:
- Estimated Revenue: ₹25–30 crore (USD 3–3.5 million) annually
- Year-on-Year Growth: Approx. 20% CAGR (2020–2023)
- Revenue Distribution: 55% Human Health, 30% Animal Health, 15% Aqua & Others
- Export Share: Over 65% of sales generated from international markets
These figures reflect increasing global demand for clinically proven and thermotolerant probiotic solutions.
Shipment Records
Based on global trade data sources such as ImportYeti and Panjiva:
- Annual Shipments: Approx. 400–500 international consignments
- Key Export Markets: USA, Vietnam, Thailand, Bangladesh, Egypt, UAE, Brazil
- Top Shipped Products: Bacillus coagulans BCP92, Multi-strain blends for livestock and shrimp
- Distribution Channels: Through distributors, OEM partners, and direct B2B clients
Pellucid has built a reliable export network supported by cold chain and shelf-stable technologies.
Target Market
Pellucid Lifesciences caters to a wide global clientele:
- Pharmaceutical and nutraceutical companies
- Animal feed and premix manufacturers
- Aqua feed integrators and hatcheries
- Veterinary nutrition companies
- Contract manufacturers and brand marketers
The company works closely with product development teams and regulatory departments to enable localized launches and dossier approvals.
Capabilities
- Manufacturing: GMP-certified fermentation and downstream processing facility in Ahmedabad
- Production Capacity: 120 MT of probiotic biomass annually
- R&D: In-house microbiology and molecular biology lab with 15+ full-time scientists
- Strain Library: 60+ proprietary isolates and ongoing metagenomic projects
- Quality Systems: In-process QA, stability testing, batch traceability, and third-party validation
Pellucid’s integrated facility supports end-to-end probiotic production under one roof, ensuring speed, customization, and compliance.
Certifications and Compliance
Pellucid Lifesciences maintains a robust regulatory framework:
- GMP Certified Manufacturing Unit
- FSSAI (India) Licensed
- HACCP-Compliant Production
- ISO 9001:2015 Certified
- Compliant with EFSA and FDA GRAS dossier standards
These certifications enable the company to serve regulated markets and meet global documentation requirements.
Customer Testimonials
“Pellucid’s Bacillus coagulans product line has helped us differentiate our brand in the functional supplement space. Their documentation and responsiveness are unmatched.”
— Sanjay K., Director, Indian Nutraceutical Company
“We’ve seen excellent gut performance and mortality reduction in shrimp farms using Pellucid’s Aqua blends. A reliable partner for our regional feed mill.”
— Nguyen H., Technical Manager, Vietnam Aqua Feed Integrator
Major Achievements
- Global Market Access: Products sold in 18+ countries with strategic alliances in Southeast Asia, MENA, and LATAM
- Research Collaboration: Partnerships with leading Indian veterinary universities and human health institutes
- Proprietary Strain Commercialization: Launched over 20 branded formulations across human and animal segments
- Technological Innovation: Development of encapsulated probiotic formats and liquid probiotic concentrates
- Sustainability Focus: Promoting antibiotic-free growth and improved environmental aquaculture outcomes
Pellucid Lifesciences Pvt. Ltd. stands at the forefront of microbial innovation, enabling a healthier and more sustainable future through science-backed probiotics tailored for global markets.
